BJU Int
- MA L, Lu R, Dong Z 
 Comment on 'Renal, bladder and prostate cancer surgery outcomes with respect to 
team familiarity'.
 BJU Int. 2025 Oct 23. doi: 10.1111/bju.70032.
 
 
 BMC Cancer
 
 
- ESMAELI M, Dehghanpour Dehabadi M 
 Curcumin in prostate cancer: a systematic review of molecular mechanisms and 
nanoformulated therapeutic strategies.
 BMC Cancer. 2025;25:1609.
 
 
- MAROTO JP, Puente J, Conde Moreno A, Juarez A, et al 
 Real-world evidence in localized and locally advanced prostate cancer: applying 
artificial intelligence to electronic health records.
 BMC Cancer. 2025;25:1618.
 
 
- CHEN H, Chen J, Lyu F, Ma M, et al 
 Comparison of the safety and efficacy of moderately hypofractionated and 
conventionally fractionated radiotherapy for localized prostate cancer: evidence 
from 9074 men in 13 randomized clinical trials.
 BMC Cancer. 2025;25:1634.
 
 
 Cancer
 
 
- GOGEBAKAN KC, Elsisi Z, Montano-Campos F, Owens L, et al 
 Prostate-specific membrane antigen positron emission tomography/computed 
tomography imaging as a precision diagnostic at prostate cancer recurrence after 
radical prostatectomy: Modeling long-term survival.
 Cancer. 2025;131:e70131.
 
 
 Cancer Lett
 
 
- NIKHIL K, Kamra M, Raza A, Shah K, et al 
 Corrigendum to "Negative cross talk between LIMK2 and PTEN promotes castration 
resistant prostate cancer pathogenesis in cells and in vivo" [Cancer Lett. 498 
(2021) 1-18].
 Cancer Lett. 2025 Oct 17:218044. doi: 10.1016/j.canlet.2025.218044.
 
 
 Cancer Res
 
 
- NASR MM, Wadie B, Li T, Frieling JS, et al 
 PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic 
Outgrowth.
 Cancer Res. 2025 Oct 17. doi: 10.1158/0008-5472.CAN-24-4809.
 
 
 Eur Urol
 
 
- FREEDLAND SJ, Shore N 
 Reply to Xianghu Meng, Yibo Hua, and Rijin Song's Letter to the Editor re: 
Stephen J. Freedland, John P. Mulhall, Martin Gleave, et al. Effects of 
Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent 
Prostate Cancer: A Post Hoc
 Eur Urol. 2025 Oct 22:S0302-2838(25)04744-X. doi: 10.1016/j.eururo.2025.09.4179.
 
 
- SCHELTEMA MJV, Stricker PD 
 Prospective Multicentre Validation of Focal Irreversible Electroporation as an 
Attractive Treatment Option for Localised Intermediate-risk Prostate Cancer.
 Eur Urol. 2025 Oct 16:S0302-2838(25)04738-4. doi: 10.1016/j.eururo.2025.
 
 
- VIGNESWARAN HT, Palsdottir T, Micoli C, Tilki D, et al 
 Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year 
Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced 
Overdiagnosis from the STHLM3 Trial.
 Eur Urol. 2025 Oct 16:S0302-2838(25)04735-9. doi: 10.1016/j.eururo.2025.
 
 
 Int J Cancer
 
 
- TANG Y, Han Z, Yi X, Li J, et al 
 Survival improvements and disparities in metastatic prostate adenocarcinoma, 
clear cell renal cell carcinoma, and urothelial carcinoma of bladder.
 Int J Cancer. 2025;157:2485-2494.
 
 
 Int J Radiat Oncol Biol Phys
 
 
- WIERSMA RG, de Vries KC, Heemsbergen WD, de Hoop EO, et al 
 Hypofractionated Dose Escalation versus Conventionally Fractionated Radiotherapy 
for Patients with Intermediate- and High-risk Localized Prostate Cancer: 
Long-term Results of the HYPRO trial.
 Int J Radiat Oncol Biol Phys. 2025 Oct 15:S0360-3016(25)06340.
 
 
 J Clin Oncol
 
 
- EINSTEIN DJ, Abel ML, Aragon-Ching JB, Arlen PM, et al 
 National Cancer Institute's Working Group on Biochemically Recurrent Prostate 
Cancer: Clinical Trial Design Considerations.
 J Clin Oncol. 2025 Oct 23:JCO2501693. doi: 10.1200/JCO-25-01693.
 
 
 J Nucl Med
 
 
- RAHBAR K, Giesel FL, Herrmann K, Yun M, et al 
 Efficacy of [(18)F]PSMA-1007 PET/CT in Primary Staging of Prostate Carcinoma: A 
Systematic Review and Metaanalysis.
 J Nucl Med. 2025 Oct 23:jnumed.125.269818. doi: 10.2967/jnumed.125.269818.
 
 
 Lancet Oncol
 
 
- KOSTOS L, Buteau JP, Xie J, Cardin A, et al 
 Lutetium-177 [(177)Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic 
castration-resistant prostate cancer (AlphaBet): an interim analysis of the 
investigator-initiated, single-centre, single-arm, phase 1/2 trial.
 Lancet Oncol. 2025 Oct 18:S1470-2045(25)00559.
 
 
 N Engl J Med
 
 
- SHORE ND, Luz MA, De Giorgi U, Gleave M, et al 
 Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.
 N Engl J Med. 2025 Oct 19. doi: 10.1056/NEJMoa2510310.
 
 
 Proc Natl Acad Sci U S A
 
 
- YUAN S, Ming DJ, He J, Liu MY, et al 
 A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation 
for prostate cancer progression.
 Proc Natl Acad Sci U S A. 2025;122:e2510386122.
 
 
 Prostate
 
 
- KAWAI T, Maki K, Taguchi S, Fujii Y, et al 
 Efficacy of Early Switching From Docetaxel to Cabazitaxel in Castration-Resistant 
Prostate Cancer.
 Prostate. 2025 Oct 21. doi: 10.1002/pros.70082.
 
 
- KIDD M, Rempega G, Kepinski M, Slomian S, et al 
 Utility of the PROSTest, a Novel Blood-Based Molecular Assay, Versus PSA for 
Prostate Cancer Stratification and Detection of Disease.
 Prostate. 2025 Oct 23. doi: 10.1002/pros.70086.
 
 
 Ther Adv Urol
 
 
- LEBRET T, Crehange G, Pello-Leprince-Ringuet N, Perrot V, et al 
 Treatment of aggressive prostate cancer with triptorelin in real life in France: 
the TALISMAN study.
 Ther Adv Urol. 2025;17:17562872251382970.
 
 
 Urology
 
 
- KHAN S, Harper A, Yang L, Sutcliffe S, et al 
 Reply to Letter to the Editor on "Impact of Age, Marital Status, Smoking, and 
Alcohol Consumption on Urinary and Sexual Function in Prostate Cancer Patients 
Treated With Radical Prostatectomy: A Prospective Cohort Study".
 Urology. 2025 Oct 16:S0090-4295(25)01008-8. doi: 10.1016/j.urology.2025.
 
 
- GILLIS CJ 
 Editorial Comment on "Patient-Centered Priorities in Prostate Cancer Survivorship 
Care".
 Urology. 2025 Oct 15:S0090-4295(25)01003-9. doi: 10.1016/j.urology.2025.
 
 
- SORENSEN KH, Levinsen AKG, Kjaer TK, Borre M, et al 
 Associations between stress urinary incontinence and self-reported functioning 
and urinary symptoms among survivors of prostate cancer treated with radical 
prostatectomy.
 Urology. 2025 Oct 15:S0090-4295(25)01011-8. doi: 10.1016/j.urology.2025.
 
 
- PICCOLINI A, Qian Z, Korn SM, Dagnino F, et al 
 Exploring the Impact of Mental Health on PSA Screening: Insights From a 
Population-Based Survey.
 Urology. 2025;204:112-120.
 
 
 
Free Medical Abstracts
 Privacy Policy
Privacy Policy
 Sponsors
Sponsors
 Share
Share
© Amedeo 1997-2016